A Randomized Active-controlled Study to Evaluate Safety and Tolerability of QLS-101 Versus Timolol Preservative Free (PF) Ophthalmic Solution in Subjects With Normal Tension Glaucoma (NTG)
Latest Information Update: 05 Apr 2023
At a glance
- Drugs QLS-101 (Primary) ; Timolol
- Indications Low tension glaucoma
- Focus Adverse reactions
- Sponsors Qlaris Bio
- 07 Oct 2022 Status changed from active, no longer recruiting to completed.
- 02 Aug 2022 Status changed from recruiting to active, no longer recruiting.
- 19 Jul 2022 Planned End Date changed from 29 Jul 2022 to 1 Sep 2022.